REACTA BIOTECH LIMITED

08553682
Active Deeside

Research and experimental development on biotechnology

55 employees website.com
Research and experimental development on biotechnology
R

REACTA BIOTECH LIMITED

08553682

Research and experimental development on biotechnology

Founded 3 Jun 2013 Active Deeside, England 55 employees website.com
Research and experimental development on biotechnology
Accounts Submitted 3 Jun 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 19 Jun 2025 Next due 23 Jun 2026 7 days remaining
Net assets £3M £1M 2024 year on year
Total assets £5M £2M 2024 year on year
Total Liabilities £2M £1M 2024 year on year
Charges 3
1 outstanding 2 satisfied

Contact & Details

Contact

Registered Address

Unit 2 Newtech Square Deeside Industrial Park Deeside CH5 2NT England

Website

www.example.com

Full company profile for REACTA BIOTECH LIMITED (08553682), an active company based in Deeside, England. Incorporated 3 Jun 2013. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type small
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£3.89M

Increased by £3.03M (+352%)

Net Assets

£3.08M

Increased by £1.09M (+55%)

Total Liabilities

£2.39M

Increased by £1.08M (+82%)

Turnover

N/A

Employees

55

Increased by 12 (+28%)

Debt Ratio

44%

Increased by 4 (+10%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1
Grants 1

Investors (1)

Investor NameInvestor SinceParticipating Rounds
Investor 1Nov 2025Venture - Series Unknown

Share Capital

Share Capital

Share allotments and capital structure

19 Allotments 1,788,607 Shares £8.75m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
15 May 202611,127£11.127£0.001
9 Apr 202417,500£17.5£0.001
27 Jul 2023356,905£500k£1.4
27 Jul 2023263,577£1.85m£7
8 Jul 20215,000£5£0.001

Officers

Officers

2 active 1 resigned
Status
Adrian Ivery FieldDirectorBritishEngland5215 Apr 2025Active
Simon Thelwall-jonesDirectorBritishUnited Kingdom5716 Oct 2023Active

Shareholders

Shareholders (58)

Dbw Investments (3) Limited
30.2%
598,125
Moulton Goodies Limited
27.4%
543,625

Persons with Significant Control

Persons with Significant Control (2)

2 Active 3 Ceased
Active
Notified 27 Jul 2023
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Jon Moulton

British

Active
Notified 1 Jun 2018
Residence Guernsey
DOB October 1950
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Professor Ashley Arthur Woodcock

Ceased 21 Jan 2020

Ceased

Professor Elizabeth Naomi Clare Mills

Ceased 1 Dec 2019

Ceased

Moulton Goodies Ltd

Ceased 1 Jun 2018

Ceased

Group Structure

Group Structure

REACTA BIOTECH LIMITED Current Company
REACTA HEALTHCARE LTD united kingdom

Charges

Charges

1 outstanding 2 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
4 Jun 2026ResolutionResolutions
19 May 2026CapitalAllotment of shares (GBP 1,993.714) on 15 May 2026
13 Mar 2026OfficersChange to director Mr Richard Nagle on 13 Mar 2026
11 Mar 2026OfficersAppointment of Mr Richard Nagle as director on 10 Mar 2026
24 Jun 2025OfficersTermination of Christopher Guy Weaver as director on 24 Jun 2025
4 Jun 2026 Resolution

Resolutions

19 May 2026 Capital

Allotment of shares (GBP 1,993.714) on 15 May 2026

13 Mar 2026 Officers

Change to director Mr Richard Nagle on 13 Mar 2026

11 Mar 2026 Officers

Appointment of Mr Richard Nagle as director on 10 Mar 2026

24 Jun 2025 Officers

Termination of Christopher Guy Weaver as director on 24 Jun 2025

Recent Activity

Latest Activity

Resolutions

1 weeks ago on 4 Jun 2026

Allotment of shares (GBP 1,993.714) on 15 May 2026

3 weeks ago on 19 May 2026

Change to director Mr Richard Nagle on 13 Mar 2026

3 months ago on 13 Mar 2026

Appointment of Mr Richard Nagle as director on 10 Mar 2026

3 months ago on 11 Mar 2026

Termination of Christopher Guy Weaver as director on 24 Jun 2025

11 months ago on 24 Jun 2025